General Information of the Compound
Compound ID |
CP0204754
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(4-fluorobenzyl)-N-(piperidin-4-yl)-1H-benzo[d]imidazol-2-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-((4-Flurophenyl)methyl)-N-4-piperidinyl-1H-benzimidazol-2-amine
1-(-Fluorobenzyl)-N-(piperidin-4-yl)-1H-benzimidazol-2-amine
1-(4-fluorobenzyl)-n-(piperidin-4-yl)-1h-benzimidazol-2-amine
1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-4-piperidinyl-
75970-64-8
75970-99-9
AC1L3WZJ
AC1Q4NSA
CHEMBL61301
DTXSID30226877
Norastemizole
SCHEMBL18200
Soltara
T 1348
Tecastemizole
Tecastemizole (USAN/INN)
Tecastemizole [USAN:INN]
Tecastemizole[USAN]
UNII-W5DCO14M05
W5DCO14M05
ZINC2303
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H21FN4
|
||||||||||||||||||
Molecular Weight |
324.403
|
||||||||||||||||||
Canonical SMILES |
Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H21FN4/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16/h1-8,16,21H,9-13H2,(H,22,23)
Show/Hide
|
||||||||||||||||||
InChIKey |
SFOVDSLXFUGAIV-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Clinical Information about the Compound